<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Coleção:</title>
  <link rel="alternate" href="https://repositorio.ufms.br/handle/123456789/4220" />
  <subtitle />
  <id>https://repositorio.ufms.br/handle/123456789/4220</id>
  <updated>2026-04-05T18:54:24Z</updated>
  <dc:date>2026-04-05T18:54:24Z</dc:date>
  <entry>
    <title>Insulinas análogas de ação rápida para o manejo de pacientes com hiperglicemia hospitalar</title>
    <link rel="alternate" href="https://repositorio.ufms.br/handle/123456789/12289" />
    <author>
      <name />
    </author>
    <id>https://repositorio.ufms.br/handle/123456789/12289</id>
    <updated>2025-07-23T13:15:18Z</updated>
    <published>2025-07-01T00:00:00Z</published>
    <summary type="text">Título: Insulinas análogas de ação rápida para o manejo de pacientes com hiperglicemia hospitalar
Abstract: NATS-Humap/UFMS recommends the temporary use of rapid-acting insulin analogs&#xD;
in situations of regular human insulin shortages, considering similar efficacy and safety.&#xD;
Prioritize the safest product among those already incorporated, especially for&#xD;
pregnant women (insulin aspart) and children, with attention to the budgetary impact, given that there is no provision for&#xD;
specific reimbursement by the SUS. The recommendation, aligned with Conitec's deliberation, aims to ensure&#xD;
continuity of care, patient safety, and hospital planning in emergency scenarios,&#xD;
highlighting the importance of clinical and pharmacoeconomic monitoring to ensure rational and&#xD;
sustainable use in the hospital setting.
Tipo: Parecer Técnico</summary>
    <dc:date>2025-07-01T00:00:00Z</dc:date>
  </entry>
</feed>

